Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Abstract

This document details the new recommendation for utilizing the 13-valent pneumococcal conjugate vaccine in place of the 23-valent polysaccharide vaccine in transplant recipients and the majority of candidates.